J Korean Med Assoc.  2005 Jan;48(1):24-33. 10.5124/jkma.2005.48.1.24.

Appropriate Pharmacotherapy in Elderly Patients

• Yoon JL

• KMID: 1722076
• DOI: http://doi.org/10.5124/jkma.2005.48.1.24

Abstract

No abstract available.

Keyword

Drug; Elderly; Adverse drug reactions

MeSH Terms

Aged*
Drug Therapy*
Drug-Related Side Effects and Adverse Reactions
Humans

Reference

7. Rathore SS, Metha SS, Boyko WL Jr, Schulman KA. Prescription medication use in older Americans: a national report card on prescribing. Fam Med. 1998. 30:733–739.

8. Giron MS, Wang HX, Bernstein C, Thorslund M, Winblad B, Fastbom J. The appropriateness of drug use in an older non-demented and demented population. J Am Geriatr Soc. 2001. 49:277–283.

9. Fugh-Berman A. Herb-drug interactions. Lancet. 2000. 355:134–138.

10. Beyth RJ, Antani MR, Covinsky KE, Miller DG, Chren MM, Landefeld CS, et al. Why isn't warfarin prescribed to patients with nonrheumatic atrial fibrillation? A study of physician's opinions and their relationship to clinical characteristics and the physician's prescribing practices. J Gen Intern Med. 1996. 11:721–728.

11. Fouts M, Hanlon J, Pieper C, Perfetto E, Feinberg J. Identification of elderly nursing facility residents at high risk for drug-related problems. Consult Pharm. 1997. 12:1103–1111.

12. Black DM, Brand RJ, Greenlick M, Hughes G, Smith J. Compliance to treatment for hypertension in elderly patients: the SHEP pilot study. J Gerontol. 1987. 43:552–557.

13. Botelho RJ, Dudrak R. Home assessment of adherence to long-term medication in the elderly. J Fam Pract. 1992. 35:61–65.

14. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med. 1990. 323:1505–1511.

15. Cooper JK, Love DW, Raffoul PR. Intentional prescription nonadherence by the elderly. J Am Geriatr Soc. 1982. 30:329–333.

16. Kane RL, Ouslander JG, Abrass IB. Essentials of clinical geriatrics. 1999. 4th ed. New York: McGraw-Hill;383.

17. Hutchinson TA, Flegel KM, Kramer MS, Leduc DG, Kong HH. Frequency, severity and risk factors for adverse drug reactions in adult outpatients: a prospective study. J Chron Dis. 1986. 39:533–542.

18. Grymonpre RE, Mitenko PA, Sitar DS, Aoki FY, Montgomery RP. Drug-associated hospital admissions in older medical patients. J Am Geriatr Soc. 1988. 36:1092–1098.

19. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med. 1997. 157:1531–1536.

20. Aparasu RR, Mort JR. Inappropriate prescribing for the elderly: Beers criteria-based review. Ann Pharmacother. 2000. 34:338–346.

21. Gurwitz JH, Avorn J. The ambiguous relation between aging and adverse drug reactions. Ann Intern Med. 1991. 114:956–966.

22. Hurwitz N. Predisposing factors in adverse reactions to drugs. BMJ. 1969. 1:536–539.

23. Johnson JA, Bootman JL. Drug-related morbidity and mortality : a cost-illness model. Arch Intern Med. 1995. 155:1949–1956.

24. Klein U, Klein M, Sturm H, et al. The frequency of adverse drug reactions as dependent upon age, sex, and duration of hospitalization. Int J Clin Pharmacol Biopharm. 1976. 13:187–195.

25. Michocki RJ. Daly MP, Weiss BD, Adelman AM, editors. Polypharmacy and principles of drug therapy. 20 common problems in geriatrics. 2001. New York: McGraw-Hill;69–81.

26. Rochon PA, Gurwitz JH. Prescribing for seniors: neither too much nor too little. JAMA. 1999. 282:113–115.